Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Hiroki Ienaga"'
Autor:
Yasuhito Sekimoto, Yoshifumi Suzuki, Koichiro Kanamori, Isao Kobayashi, Hiroki Ienaga, Kazuhisa Takahashi
Publikováno v:
Respirology Case Reports, Vol 10, Iss 6, Pp n/a-n/a (2022)
Abstract Electroconvulsive therapy (ECT) has been used for many years as an important treatment modality in patients with schizophrenia. Recently, many new oral medications have become available to treat schizophrenia. However, ECT remains a valuable
Externí odkaz:
https://doaj.org/article/cad1403532b7432a92d25e85e048bc91
Autor:
Shouichi Okamoto, Isao Kobayashi, Hiroshi Moriyama, Mayuka Tanimura, Kotaro Kadoya, Hiroki Ienaga, Toshiaki Kikuchi, Kazuhisa Takahashi
Publikováno v:
Respiratory Medicine Case Reports, Vol 37, Iss , Pp 101665- (2022)
Pleural disease in silicosis remains an underrecognized entity. Herein, we describe the case of an 85-year-old man with a 20-year history of silica exposure between the ages of 9–28 years. He presented with bilateral exudative pleural effusions, an
Externí odkaz:
https://doaj.org/article/b598387d9fc7454198e7b5ea1851cf7d
Autor:
Hiroyuki Shimizu, Brendan J. Barrett, Koh Okamoto, Akihiro Ueda, Kazutoshi Iijima, Shigeru Mikami, Ayumu Tsubosaka, Kansei Watanabe, Hideaki Kato, Fan Yang, Makoto Yabe, Natsuo Tachikawa, Bohua Ma, Kazuki Taoka, Yohei Doi, Sakura Davis, Kazuyoshi Kurashima, Kyoji Moriya, Mai Takematsu, Ikura Hashimoto, Shota Sugiyama, Hiroki Ienaga, Yasushi Shibue, Sohei Harada, Yusuke Yoshino, Styve Pamphile, Masao Hagihara, Masaki Ishihara, Saki Namura, Eiki Shoji, Hideaki Nakajima
Publikováno v:
SSRN Electronic Journal.
Background: It has been difficult to distinguish between mild, moderate, and severe cases at an early stage for COVID-19 patients, making it challenging to decide an optimized treatment for each patient. This machine learning system could predict the
Autor:
Satomi Shiota, Yoshiteru Morio, Shin-ichiro Iwakami, Liu Zuoyou, Yoshinosuke Fukuchi, Kazuhisa Takahashi, Ai Sugiyama, Hiroki Ienaga, Mitsuaki Sekiya
Publikováno v:
Respiratory physiologyneurobiology. 262
Pulmonary hypertension (PH) due to lung diseases is classified as group 3 by the Dana Point classification. Given the basic pathophysiological conditions of group 3 lung diseases and the previously well-known concept of hypercapnic pulmonary vasocons
Autor:
Yoshiteru Morio, Tetsutaro Nagaoka, Katsutoshi Ando, Takeo Tsutsumi, Toru Kimura, Kazuhisa Takahashi, Hiroshi Kuraishi, Hiroki Ienaga, Yoshito Hoshika
Publikováno v:
Lung. 193(6)
Recent imaging studies demonstrated the usefulness of quantitative computed tomographic (CT) analysis assessing pulmonary hypertension (PH) in patients with chronic obstructive lung disease (COPD–PH). The aim of this study was to investigate whethe
Autor:
Kayo Maeda, Hiroki Ienaga, Fumiyuki Takahashi, Kazuhisa Takahashi, Masahiro Maeda, Yoshinosuke Fukuchi, Shigeyuki Kon, Toshimitsu Uede, Tatsuma Okazaki
Publikováno v:
American Journal of Respiratory Cell and Molecular Biology. 24:264-271
Pulmonary fibrosis is initiated by migration, adhesion, and proliferation of fibroblasts. Osteopontin (OPN) is one of the cytokines produced by activated macrophages and mediates various functions, including cell attachment and migration, by interact
Autor:
Yuichi Fujimoto, Hiroki Ienaga, Kazunori Tobino, Isao Kobayashi, Koji Sugano, Kazuhisa Takahashi, Motoyasu Kato, Hitoshi Tokuda
Publikováno v:
BMC Research Notes
Background Tacrolimus is an immunosuppressive drug used to prevent acute rejection following organ transplantation and to treat autoimmune disease. Tacrolimus is usually prescribed in such situation at a dose of 3.0 mg/day. Pneumocystis pneumonia ind
Publikováno v:
Juntendo Medical Journal. 39:1-10
Publikováno v:
Haigan. 31:929-935
肺癌で, 上大静脈症候群は重篤な病態としてよく知られているが, 下大静脈 (IVC) の閉塞をきたすことは稀とされている. 最近我々は, IVC狭窄をきたした肺癌, 4症例を経験した. これらの症
Autor:
Takashi Dambara, Hideki Takahashi, Yoshinosuke Fukuchi, Hiroki Ienaga, Jun Ueki, Mitsuaki Sekiya
Publikováno v:
Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics. 36(10)
Although sarcoidosis is generally considered a disease of young and middle aged adults, there have been a certain number of cases among elderly. However it is unknown whether sarcoidosis in the elderly is recurrence of prior disease or initial onset